Search Discussions
View Discussions Replied ToDiscussions Started
arnold replied Apr 23, 2013 to Sarepta and their push for Accelerated Approval of Eteplirsen
arnold replied Nov 15, 2011 to AVI Enters Into Collaborations for the Development of Two Additional Exon-Skipping Products for Duchenne Muscular Dystrophy (DMD)
arnold replied Sep 18, 2011 to Exon Skipping Confusion
arnold replied Jun 15, 2011 to AVI Eteplirsen Trial
arnold replied May 5, 2011 to Daily pill for Duchenne muscular dystrophy
arnold replied Apr 14, 2011 to AVI BioPharma Receives Approval of Nonproprietary Name Eteplirsen for Lead Duchenne Muscular Dystrophy Therapeutic Candidate, AVI-4658
arnold replied Apr 13, 2011 to AVI BioPharma Receives Approval of Nonproprietary Name Eteplirsen for Lead Duchenne Muscular Dystrophy Therapeutic Candidate, AVI-4658
arnold replied Apr 12, 2011 to AVI BioPharma Receives Approval of Nonproprietary Name Eteplirsen for Lead Duchenne Muscular Dystrophy Therapeutic Candidate, AVI-4658
arnold replied Mar 11, 2011 to GSK trial of exon 51 skipping on Ambulatory Boys
RSS
Welcome toPPMD Community
Sign Upor Sign In
Or sign in with:
Need help using this community site? Visit Ning's Help Page.
Terms of Service
© 2022 Created by PPMD. Powered by
Badges | Report an Issue | Privacy Policy | Terms of Service
Please check your browser settings or contact your system administrator.